| Factor Information | |
|---|---|
| Data ID | 2649 |
| Factor | Dopamine |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | We tested the hypothesis that milrinone is an independent risk factor for tachyarrhythmias after congenital heart surgery. |
| p Value | 0.009 |
| OR | 1.7 |
| Conclusion | In conclusion, milrinone use is an independent risk factor for clinically significant tachyarrhythmias in the early postoperative period after congenital heart surgery. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 612 |
| CHD Type | isolated CHD |
| CHD Subtype | HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
| Reference | |
|---|---|
| PMID | 21890079 |
| Year | 2011 |
| Title | Relation of Milrinone After Surgery for Congenital Heart Disease to Significant Postoperative Tachyarrhythmias |
| Sample | ||
|---|---|---|
| Population | infants and children | |
| Source | patients' data | |
| Region | Tennessee, America | |
| Method | univariate analysis | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | surgery | |
| Group | without tachyarrhythmia incidence requiring intervention before cardiac intensive care unit (CICU) discharge(Treatment) | with tachyarrhythmia incidence requiring intervention before cardiac intensive care unit (CICU) discharge(Control) |
| Number | 457 | 267 |
| Age | N/A | N/A |
| Gender (Male: Female) | 305:271 | 92:56 |
| Marker Level | 162 (28%) | 62 (40%) |
